“…Some studies specifically focused on very low birth weight
newborns 19,44,48 and extremely low
gestational age newborns 16,17 which are premature populations with expected risk of
illness severity. Not only was the SNAP-II used across all gestational ages and birth
weights, it was also used across many specific morbidities including: congenital
diaphragmatic hernia, 15,21,24,25,28,29 chorioamnionitis, 27,48 sepsis, 33–36,39 gastroschisis, 20,26 patent
ductus arteriosus, 19,22 persistent pulmonary hypertension, 42 and respiratory distress. 45 …”